PubMed · 10306394
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
R A Gosselin. 1978. The Maximum Allowable Cost program--some marketing consequences.. https://pubmed.ncbi.nlm.nih.gov/10306394/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
In order to facilitate a better understanding of the complex issues raised by the current Senate and House proposals to establish a prescription drug benefit for Medicare beneficiaries, this paper briefly addresses some fundamentals of the health insurance market, defines key risk-sharing mechanisms, including risk corridors and reinsurance, and identifies the relevant risk provisions in the bills. Other issues related to cost management strategies and program design, which may have an impact on cost and adverse selection, are briefly discussed.
Explore the source record for details and available documents.